This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clinical features

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The clinical manifestations are seldom characteristic and are often masked by those related to the background of cirrhosis or chronic hepatitis. HCC should be suspected if a patient with cirrhosis deteriorates without obvious reason or if ascites fails to resolve despite adequate treatment.

Hepatocellular carcinoma is three times more common in males.

Clinical effects of the primary disease include:

  • general - malaise, fatigue
  • gastrointestinal - anorexia, jaundice, constipation, ill-defined upper abdominal pain, abdominal fullness, bleeding oesophageal varices
  • hepatomegaly - liver is often irregular or nodular, and may be tender
  • ascites
  • dyspnoea - a late finding; may indicate diaphragmatic involvement or compression, or pulmonary metastases

Effects of metastases include:

  • pulmonary - pulmonary embolus, pleural effusion
  • bone - pain
  • brain - confusion, raised intracranial pressure
  • lymphadenopathy - particularly, enlargement of right supra-clavicular lymph glands

Systemic effects are rarely florid in HCC. Paraneoplastic syndromes include:

  • gynaecomastia - increased secretion of oestrogen
  • hypercalcaemia - secretion of parathormone-like hormone
  • hypoglycaemia - glucose demand from tumour mass
  • hyperthyroidism - inappropriate TSH production

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.